High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset, clinical trial finds
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
Medscape14d
High-Dose Vitamin D Curbs Disease Activity in Early Multiple Sclerosis
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
Medical Dialogues9d
Brief Review on Vitamin D Formulations: Spotlight on Nanoemulsion and Its Innovations
Deficiency and insufficiency of vitamin D is a global concern, affecting a vast proportion of the Indian population as well; ...
European Medical Journal5d
Vitamin D Significantly Reduces MS Disease Activity, Landmark Trial Shows
HIGH-DOSE vitamin D supplementation significantly reduces disease activity in patients with clinically isolated syndrome (CIS ...
MedPage Today17d
High-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis
Over 24 months of follow-up, disease activity occurred in 60.3% of the group taking 100,000 IU oral cholecalciferol (vitamin D3) every 2 weeks and 74.1% of the placebo group (HR 0.66, 95% CI 0.50 ...